BroadEye: An Ophthalmology Podcast

Retinitis Pigmentosa, Rowing For Gold and Olympic Dreams - Victoria Nolan

Victoria Nolan shares her story of vision loss due to Retinitis Pigmentosa and how she was drawn to start rowing at age 30, eventually earning a spot on the Canadian national adaptive rowing team. Victoria further shares stories of her experience as a guide dog handler and her current training for the Tokyo Olympic Games.

 

 

 

Age-related Macular Degeneration (AMD) - Dr. Stephen McIntosh

Dr. Stephen McIntosh provides a high-level overview of Age-related Macular Degeneration (AMD), including modifiable and non-modifiable risk factors, basic treatment approaches, a scientific explanation for the cause of the disease, and thoughts on why the disease etiology is complicated and not completely understood.

Artificial Intelligence Meets Ophthalmology With DIAGNOS

Andre Larente, President of DIAGNOS, explains how artificial intelligence is impacting the field of ophthalmology, enabling for early detection of diabetic retinopathy and other blinding eye diseases. Mr. Larente further explains how his companies technology can detect early signs of non-ocular conditions, including stroke.

Retinitis Pigmentosa: The Arrival of Gene Therapy and What Comes Next - Dr. Cynthia X. Qian

Dr. Cynthia X. Qian shares an in-depth overview of Retinitis Pigmentosa, highlighting potential treatment approaches at various stages of disease progression. Dr. Qian
further describes the first approved gene therapy for a specific type of Retinitis Pigmentosa and how this therapy sets the stage for targeted gene therapies for various inherited retinal dystrophies in the near future.

Retinal Implants, Ocular Gene Therapy, and the Importance of Genetic Testing for Inherited Retinal Dystrophies - Dr. Flavio Rezende

In this episode, Dr. Flavio Rezende explores the current state of affairs for retinal implants in Canada and worldwide, highlighting some of the benefits and limitations of the technology.

Dr. Rezende further provides an overview of gene therapy for inherited retinal dystrophies, explaining why such treatments seem to advance slowly and how the recent pandemic and improved access to genetic testing may accelerate the development of additional sight-saving ocular gene therapies.

Ocular Oncology: A Simple Tech Solution To a Faster Diagnosis - Dr. Rubens Belfort

In this episode, Dr. Rubens Belfort talks about OncoPhone, A simple, free, easy-to-access service for regional ophthalmologists who require clinical advice about suspected ocular cancers. Dr. Belfort explains why he pioneered this initiative in the field of ocular oncology in Brazil, how the initiative has been received, how it has helped ophthalmologists and patients, and how others can do the same for other rare ocular diseases.

Ophthalmology and COVID-19, Failed Technologies, and John Lennon’s Glasses - Dr. Natalia Villa

Dr. Natalia Villa shares her experience working as a retinal surgeon in the United Kingdom during the first wave of COVID-19 and then in Canada during the second wave. Dr. Villa further shares stories of retinal implants that never made it to market, patents that may never make it to the clinic, the rise of technology in ophthalmology, and a high-security visit centered around John Lennon‘s glasses.

Retinitis Pigmentosa, the Pros and Cons of Genetic Testing and What it’s like Raising Low Vision Children - Greg Dubecky

Greg Dubecky sheds light on raising a child with low vision, trying to understand retinitis pigmentosa research as a layperson and the need for knowledge transfer in ophthalmology.

Dry Eye: What Is It and What Can Patients Do About It - Dr. Stephen McIntosh

Dr. Stephen McIntosh explains what dry eye is and how it can be recognized and treated, drawing on years of experience as an optometrist practising in diverse rural and urban settings.

BroadEYE - bridging the knowledge gap in ophthalmology and eye care

In this episode, Dr. Shawn Maloney and Dr. Bruno Fernandes discuss the impetus for creating the podcast, highlighting the gaps in what patients, physicians, researchers, and industry professionals in ophthalmology and eye care know and understand.